Fischer Medical Ventures Ltd

Fischer Medical Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Fischer Medical Ventures Ltd

₹ 856 -0.52%
10 Jun - close price
fischermv.com BSE: 524743
About

Incorporated in 1993, Fischer Chemic Ltd does trading of chemicals and machineries[1]

Key Points

Business Overview:[1]
Company is in the business of processing, manufacturing and trading of Laboratory Grade Chemicals

Website BSE
  • Market Cap ₹ 5,551 Cr.
  • Current Price ₹ 856
  • High / Low ₹ 919 / 574
  • Stock P/E 4,626
  • Book Value ₹ 52.9
  • Dividend Yield 0.00 %
  • ROCE 1.07 %
  • ROE 0.57 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Stock is trading at 16.2 times its book value
  • Promoter holding has decreased over last quarter: -13.1%
  • Company might be capitalizing the interest cost
  • Earnings include an other income of Rs.1.49 Cr.
  • Company has high debtors of 251 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
0.00 20.79 10.12 39.66 11.75 49.17
0.00 18.28 10.29 39.16 11.38 46.77
Operating Profit 0.00 2.51 -0.17 0.50 0.37 2.40
OPM % 12.07% -1.68% 1.26% 3.15% 4.88%
0.00 0.47 0.65 0.05 0.38 0.15
Interest 0.00 0.05 0.13 0.05 0.07 0.23
Depreciation 0.00 0.18 0.28 0.29 0.56 0.51
Profit before tax 0.00 2.75 0.07 0.21 0.12 1.81
Tax % 6.18% 271.43% -38.10% 350.00% 27.62%
0.00 2.59 -0.12 0.29 -0.29 1.32
EPS in Rs 0.00 0.48 -0.02 0.05 -0.05 0.24
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025
0 21 111
0 19 108
Operating Profit 0 2 3
OPM % 11% 9% 3%
0 0 1
Interest 0 0 0
Depreciation 0 0 2
Profit before tax 0 2 2
Tax % 13% 45%
-0 2 1
EPS in Rs -2.33 0.34 0.23
Dividend Payout % 0% 0% 18%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 428%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -35%
Stock Price CAGR
10 Years: 73%
5 Years: 80%
3 Years: 136%
1 Year: 31%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 1%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025
Equity Capital 0.17 54 64
Reserves -0 28 274
1 2 85
0 4 34
Total Liabilities 0 86 457
0 15 24
CWIP 0 0 1
Investments 0 1 11
0 70 422
Total Assets 0 86 457

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025
-8 -86
-29 -125
37 315
Net Cash Flow 1 103

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025
Debtor Days 345 398 251
Inventory Days 36
Days Payable 82
Cash Conversion Cycle 345 398 205
Working Capital Days 324 505 265
ROCE % 5% 1%

Shareholding Pattern

Numbers in percentages

Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Apr 2025
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 74.91% 74.91% 74.91% 62.82% 61.80%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 5.07% 5.07% 5.07% 5.07% 5.23% 5.38%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.68% 1.68% 1.68% 1.68% 1.44% 1.42%
100.00% 100.00% 100.00% 99.99% 100.00% 99.99% 93.24% 18.33% 18.33% 18.32% 30.51% 31.41%
No. of Shareholders 9,1219,0649,0609,1009,1049,0388,9769,2859,5029,68810,18010,182

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Concalls

  • Dec 2024
    Transcript
    Notes
    PPT